RxDoctor Payments Data

Jeffrey Gahan

Urology · Ft Worth, TXNPI 1679713960

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Angiodynamics, Inc. at 28.1% of the total. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.

$3,685in general payments, 2019–2025

Across 43 payments — averaging $85.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$1K
  • Boston Scientific$739
  • EDAP Technomed Inc$605
  • Procept Biorobotics Corporation$255
  • Medtronic$240
  • Immunitybio, Inc.$150
  • plus $661 from 11 others
$120,461in research payments, 2019–2025

Across 17 payments — averaging $7085.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Angiodynamics, Inc.$105K
  • Janssen Research & Development, LLC$16K

What the payments were for

  • Food & beverage$3,685100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,685 in reported general payments places this provider in the 50th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Medicare billing

Part B allowed, 2024
$91,877
Medicare patients
243
Services billed
1,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron12$5,727
Tamsulosin Hcl31$352
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$155

Paid to pharmacies, not to this prescriber.

Other urology in Ft Worth

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →